FDA Panel Votes to Recommend Pfizer Vaccine for Emergency Authorization

An FDA panel voted 17–4 to give emergency use authorization to the Pfizer vaccine.

A panel of advisers to the FDA voted on December 10 to recommend that Pfizer’s COVID-19 vaccine be given emergency use authorization, according to NPR.

The 17–4 vote decided that the benefits of the vaccine outnumbered the risks. On the heels of Britain’s approval of the vaccine, the FDA is expected to decide on emergency authorization for the United States soon.

The FDA’s analysis of the Pfizer vaccine was released on December 8. It contained documents that support the emergency authorization. It was determined during a pre-meeting analysis on December 4 that there were “no specific safety concerns identified that would preclude the issuance of an EUA.”

To read more about the FDA’s analysis of the Pfizer vaccine, visit fda.gov.

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021


      Managing Combustible Dust and Risk Mitigation
      The Rising Popularity of Safety Helmets on the Jobsite
      Five Tips for a Successful Wear Trial
      Medical Surveillance Versus Medical Screening
    View This Issue